Literature DB >> 27125981

Umbilical cord blood transplantation is a suitable option for consolidation of acute myeloid leukemia with FLT3-ITD.

Craig E Eckfeldt1, Nicole Randall1, Ryan M Shanley2, Sophia Yohe3, Nelli Bejanyan1, Michelle Dolan3, Erica D Warlick1, Michael R Verneris4, Claudio G Brunstein1, John E Wagner4, Daniel J Weisdorf1, Celalettin Ustun5.   

Abstract

Entities:  

Keywords:  FLT3-ITD; acute myeloid leukemia; allogeneic hematopoietic cell transplantation; umbilical cord blood

Mesh：

Substances：

Year:  2016        PMID： 27125981      PMCID： PMC4967587          DOI： 10.3324/haematol.2016.143628

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  28 in total

1.  Immune reconstitution and outcome after unrelated cord blood transplantation: a single paediatric institution experience.

Authors:  P Giraud; I Thuret; D Reviron; H Chambost; C Brunet; G Novakovitch; C Farnarier; G Michel
Journal:  Bone Marrow Transplant       Date:  2000-01       Impact factor: 5.483

2.  Improved outcome after stem-cell transplantation in FLT3/ITD-positive AML.

Authors:  Martin Bornhäuser; Thomas Illmer; Markus Schaich; Silke Soucek; Gerhard Ehninger; Christian Thiede
Journal:  Blood       Date:  2007-03-01       Impact factor: 22.113

3.  Patient-specific analysis of FLT3 internal tandem duplications for the prognostication and monitoring of acute myeloid leukemia.

Authors:  Joanna Schiller; Inka Praulich; Cristiano Krings Rocha; Karl-Anton Kreuzer
Journal:  Eur J Haematol       Date:  2012-05-09       Impact factor: 2.997

4.  The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials.

Authors:  P D Kottaridis; R E Gale; M E Frew; G Harrison; S E Langabeer; A A Belton; H Walker; K Wheatley; D T Bowen; A K Burnett; A H Goldstone; D C Linch
Journal:  Blood       Date:  2001-09-15       Impact factor: 22.113

5.  Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis.

Authors:  Mary Eapen; Vanderson Rocha; Guillermo Sanz; Andromachi Scaradavou; Mei-Jie Zhang; William Arcese; Anne Sirvent; Richard E Champlin; Nelson Chao; Adrian P Gee; Luis Isola; Mary J Laughlin; David I Marks; Samir Nabhan; Annalisa Ruggeri; Robert Soiffer; Mary M Horowitz; Eliane Gluckman; John E Wagner
Journal:  Lancet Oncol       Date:  2010-07       Impact factor: 41.316

6.  Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis.

Authors:  J N Barker; S M Davies; T DeFor; N K Ramsay; D J Weisdorf; J E Wagner
Journal:  Blood       Date:  2001-05-15       Impact factor: 22.113

7.  Allo-SCT for high-risk AML-CR1 in the molecular era: impact of FLT3/ITD outweighs the conventional markers.

Authors:  S M Sengsayadeth; M Jagasia; B G Engelhardt; A Kassim; S A Strickland; S Goodman; C Lucid; C L Vnencak-Jones; J P Greer; B N Savani
Journal:  Bone Marrow Transplant       Date:  2012-06-04       Impact factor: 5.483

8.  No evidence that FLT3 status should be considered as an indicator for transplantation in acute myeloid leukemia (AML): an analysis of 1135 patients, excluding acute promyelocytic leukemia, from the UK MRC AML10 and 12 trials.

Authors:  Rosemary E Gale; Robert Hills; Panagiotis D Kottaridis; Sivatharsini Srirangan; Keith Wheatley; Alan K Burnett; David C Linch
Journal:  Blood       Date:  2005-08-02       Impact factor: 22.113

9.  Umbilical Cord Blood Transplantation Outcomes in Acute Myelogenous Leukemia/Myelodysplastic Syndrome Patients Aged ≥70 Years.

Authors:  Karamjeet S Sandhu; Claudio Brunstein; Todd DeFor; Nelli Bejanyan; Mukta Arora; Erica Warlick; Daniel Weisdorf; Celalettin Ustun
Journal:  Biol Blood Marrow Transplant       Date:  2015-09-28       Impact factor: 5.742

10.  Myeloablative, but not Reduced-Intensity, Conditioning Overcomes the Negative Effect of Flow-Cytometric Evidence of Leukemia in Acute Myeloid Leukemia.

Authors:  Celalettin Ustun; Elizabeth L Courville; Todd DeFor; Michelle Dolan; Nicole Randall; Sophia Yohe; Nelli Bejanyan; Erica Warlick; Claudio Brunstein; Daniel J Weisdorf; Michael A Linden
Journal:  Biol Blood Marrow Transplant       Date:  2015-11-10       Impact factor: 5.742
View more
  1 in total

1.  Outcomes of UCB transplantation are comparable in FLT3+ AML: results of CIBMTR, EUROCORD and EBMT collaborative analysis.

Authors:  C Ustun; F Giannotti; M-J Zhang; H-L Wang; C Brunstein; M Labopin; V Rocha; M de Lima; F Baron; B M Sandmaier; M Eapen; E Gluckman; A Nagler; D J Weisdorf; A Ruggeri
Journal:  Leukemia       Date:  2017-01-25       Impact factor: 11.528
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.